Free Trial
→ What Steve Bannon revealed about Trump’s gold play (From Reagan Gold Group) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
EVKG
Ever-Glory International Group
$0.00
$0.00
$0.00
▼
$0.01
$10K3.9710,931 shs115 shs
MGO Global, Inc. stock logo
MGOL
MGO Global
$0.31
-33.8%		$0.31
$0.10
▼
$6.99
$894K7.2628.62 million shs106.10 million shs
On Holding AG stock logo
ONON
ON
$45.52
-1.1%		$48.99
$34.59
▼
$64.05
$29.00B2.237.06 million shs5.23 million shs
Silo Pharma, Inc. stock logo
SILO
Silo Pharma
$0.61
+1.6%		$0.65
$0.41
▼
$3.37
$5.65M0.3299,920 shs151,659 shs
These 7 Stocks Will Be Magnificent in 2025 Cover
These 7 Stocks Will Be Magnificent in 2025

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
EVKG
Ever-Glory International Group
0.00%0.00%0.00%0.00%0.00%
MGO Global, Inc. stock logo
MGOL
MGO Global
0.00%0.00%0.00%0.00%-87.97%
On Holding AG stock logo
ONON
ON
-1.16%+1.04%-2.75%-19.55%-0.39%
Silo Pharma, Inc. stock logo
SILO
Silo Pharma
+1.63%-2.83%+2.04%+5.06%-45.97%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
EVKG
Ever-Glory International Group
$0.00
$0.00
$0.00
▼
$0.01
$10K3.9710,931 shs115 shs
MGO Global, Inc. stock logo
MGOL
MGO Global
$0.31
-33.8%		$0.31
$0.10
▼
$6.99
$894K7.2628.62 million shs106.10 million shs
On Holding AG stock logo
ONON
ON
$45.52
-1.1%		$48.99
$34.59
▼
$64.05
$29.00B2.237.06 million shs5.23 million shs
Silo Pharma, Inc. stock logo
SILO
Silo Pharma
$0.61
+1.6%		$0.65
$0.41
▼
$3.37
$5.65M0.3299,920 shs151,659 shs
These 7 Stocks Will Be Magnificent in 2025 Cover
These 7 Stocks Will Be Magnificent in 2025

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
EVKG
Ever-Glory International Group
0.00%0.00%0.00%0.00%0.00%
MGO Global, Inc. stock logo
MGOL
MGO Global
0.00%0.00%0.00%0.00%-87.97%
On Holding AG stock logo
ONON
ON
-1.16%+1.04%-2.75%-19.55%-0.39%
Silo Pharma, Inc. stock logo
SILO
Silo Pharma
+1.63%-2.83%+2.04%+5.06%-45.97%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
EVKG
Ever-Glory International Group
0.00
N/AN/AN/A
MGO Global, Inc. stock logo
MGOL
MGO Global
0.00
N/AN/AN/A
On Holding AG stock logo
ONON
ON
2.91
Moderate Buy$64.2041.03% Upside
Silo Pharma, Inc. stock logo
SILO
Silo Pharma
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest MGOL, SILO, EVKG, and ONON Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/13/2025
On Holding AG stock logo
ONON
ON
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Price TargetOverweight$62.00 ➝ $65.00
8/13/2025
On Holding AG stock logo
ONON
ON
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Price TargetOverweight$68.00 ➝ $69.00
8/13/2025
On Holding AG stock logo
ONON
ON
Jefferies Financial Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Price TargetHold ➝ Underperform$50.00 ➝ $40.00
8/13/2025
On Holding AG stock logo
ONON
ON
Jefferies Financial Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated RatingHold ➝ Underperform$50.00 ➝ $40.00
8/13/2025
On Holding AG stock logo
ONON
ON
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Price TargetBuy$75.00 ➝ $79.00
8/12/2025
On Holding AG stock logo
ONON
ON
Needham & Company LLC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated RatingBuy$62.00
8/7/2025
On Holding AG stock logo
ONON
ON
Telsey Advisory Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated RatingOutperform$65.00
7/22/2025
On Holding AG stock logo
ONON
ON
Raymond James Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		DowngradeStrong-Buy ➝ Outperform$66.00
(Data available from 9/6/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
EVKG
Ever-Glory International Group
N/AN/AN/AN/AN/AN/A
MGO Global, Inc. stock logo
MGOL
MGO Global
$5.20M0.17N/AN/A$0.64 per share0.48
On Holding AG stock logo
ONON
ON
$2.63B10.88$0.57 per share79.54$2.51 per share18.14
Silo Pharma, Inc. stock logo
SILO
Silo Pharma
$70K81.98N/AN/A$1.12 per share0.55
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
EVKG
Ever-Glory International Group
N/AN/A0.00∞N/AN/AN/AN/AN/A
MGO Global, Inc. stock logo
MGOL
MGO Global
-$7.14M-$4.57N/A∞N/A-142.93%-412.85%-291.72%N/A
On Holding AG stock logo
ONON
ON
$275.23M$0.45101.1652.936.604.45%8.75%5.10%11/11/2025 (Estimated)
Silo Pharma, Inc. stock logo
SILO
Silo Pharma
-$4.39M-$1.05N/A∞N/A-6,798.61%-94.39%-68.62%11/10/2025 (Estimated)

Latest MGOL, SILO, EVKG, and ONON Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/13/2025Q2 2025
Silo Pharma, Inc. stock logo
SILO
Silo Pharma
N/A-$0.19N/A-$0.19N/A$0.02 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
EVKG
Ever-Glory International Group
N/AN/AN/AN/AN/A
MGO Global, Inc. stock logo
MGOL
MGO Global
N/AN/AN/AN/AN/A
On Holding AG stock logo
ONON
ON
N/AN/AN/AN/AN/A
Silo Pharma, Inc. stock logo
SILO
Silo Pharma
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
EVKG
Ever-Glory International Group
N/AN/AN/A
MGO Global, Inc. stock logo
MGOL
MGO Global
N/A
14.13
8.37
On Holding AG stock logo
ONON
ON
0.31
2.53
2.00
Silo Pharma, Inc. stock logo
SILO
Silo Pharma
N/A
6.07
6.07

Institutional Ownership

CompanyInstitutional Ownership
EVKG
Ever-Glory International Group
N/A
MGO Global, Inc. stock logo
MGOL
MGO Global
1.05%
On Holding AG stock logo
ONON
ON
36.39%
Silo Pharma, Inc. stock logo
SILO
Silo Pharma
5.58%

Insider Ownership

CompanyInsider Ownership
EVKG
Ever-Glory International Group
35.53%
MGO Global, Inc. stock logo
MGOL
MGO Global
12.60%
On Holding AG stock logo
ONON
ON
68.57%
Silo Pharma, Inc. stock logo
SILO
Silo Pharma
4.37%
CompanyEmployeesShares OutstandingFree FloatOptionable
EVKG
Ever-Glory International Group
4,30014.66 millionN/ANot Optionable
MGO Global, Inc. stock logo
MGOL
MGO Global
72.90 million2.54 millionNot Optionable
On Holding AG stock logo
ONON
ON
3,254629.65 million197.90 millionOptionable
Silo Pharma, Inc. stock logo
SILO
Silo Pharma
29.40 million8.99 millionNot Optionable

Recent News About These Companies

Silo Pharma secures Australian patent covering licensed PTSD drug candidate
September 3 at 4:34 PM  |  msn.comhttps://www.msn.com/en-us/health/other/silo-pharma-secures-australian-patent-covering-licensed-ptsd-drug-candidate/ar-AA1LNI3y
Silo Flat on Securing Australian Patent
September 3 at 11:33 AM  |  baystreet.cahttps://www.baystreet.ca/stockstowatch/21564/Silo-Flat-on-Securing-Australian-Patent
Silo Pharma, Inc. Secures Patent for SPC-15, Advancing PTSD Treatment Development
September 3 at 8:31 AM  |  quiverquant.comQ
Silo Pharma Secures Australian Patent Covering Licensed PTSD Drug Candidate Expanding Global IP Portfolio
September 3 at 8:25 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/09/03/3143596/0/en/silo-pharma-secures-australian-patent-covering-licensed-ptsd-drug-candidate-expanding-global-ip-portfolio.html
Silo Pharma’s Alzheimer’s Candidate SPC-14 Featured in Leading Scientific Peer-reviewed Journal
August 21, 2025  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/silo-pharma-s-alzheimer-s-candidate-spc-14-featured-in-leading-scientific-peer-reviewed-journal-1035062686
Silo Pharma, Inc. Announces Publication of Preclinical Research on Alzheimer's Therapeutic SPC-14 in Alzheimer’s Research & Therapy
August 21, 2025  |  quiverquant.comQ
Silo Pharma's Alzheimer's Candidate SPC-14 Featured in Leading Scientific Peer-reviewed Journal
August 21, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/08/21/3137424/0/en/silo-pharma-s-alzheimer-s-candidate-spc-14-featured-in-leading-scientific-peer-reviewed-journal.html
Silo Pharma’s PTSD Candidate SPC-15 Achieves Positive Safety Milestone, Paving Way for Accelerated Clinical Trials Under 505(b)(2) Pathway
August 19, 2025  |  manilatimes.netM
Silo Pharma's PTSD Candidate SPC-15 Achieves Positive Safety Milestone, Paving Way for Accelerated Clinical Trials Under 505(b)(2) Pathway
August 19, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/08/19/3135664/0/en/silo-pharma-s-ptsd-candidate-spc-15-achieves-positive-safety-milestone-paving-way-for-accelerated-clinical-trials-under-505-b-2-pathway.html
Silo Pharma Second Quarter 2025 Earnings: US$0.19 loss per share (vs US$0.30 loss in 2Q 2024)
August 15, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/silo-pharma-second-quarter-2025-124425916.html
Sever Pharma expands work on ketamine implant with Silo Pharma
August 11, 2025  |  pharmatimes.comP
Silo Pharma Leaps into Crypto with Corwin Yu at the Helm: A Shrewd Move or a Precarious Gamble?
August 6, 2025  |  nai500.comN
Silo Pharma launches crypto treasury strategy with Bitcoin focus
August 6, 2025  |  investing.comhttps://www.investing.com/news/cryptocurrency-news/silo-pharma-launches-crypto-treasury-strategy-with-bitcoin-focus-432SI-4170201
Silo Pharma Appoints Crypto Infrastructure Pioneer Corwin Yu to Launch Institutional Bitcoin, Ethereum and Solana Treasury Platform
August 5, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/08/05/3127380/0/en/silo-pharma-appoints-crypto-infrastructure-pioneer-corwin-yu-to-launch-institutional-bitcoin-ethereum-and-solana-treasury-platform.html
Silo Pharma Announces Completion of Dosing in Safety Study of PTSD Drug SPC-15
July 16, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/07/16/3116424/0/en/silo-pharma-announces-completion-of-dosing-in-safety-study-of-ptsd-drug-spc-15.html
Silo Pharma Secures Exclusive License for CNS Peptides
July 10, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/silo-pharma-secures-exclusive-license-for-cns-peptides?utm_source=marketbeat.com&utm_medium=referral
Silo Pharma, Inc. Plans IND Application Submission for PTSD Drug SPC-15 with Potential Phase 1 Trial in 2026 - Nasdaq
July 9, 2025  |  nasdaq.comhttps://www.nasdaq.com/articles/silo-pharma-inc-plans-ind-application-submission-ptsd-drug-spc-15-potential-phase-1-trial
Silo Pharma, Inc. Plans IND Application Submission for PTSD Drug SPC-15 with Potential Phase 1 Trial in 2026
July 7, 2025  |  quiverquant.comQ
Silo Pharma Advances PTSD Drug SPC-15 Toward Planned 2025 IND Submission with Pre-Clinical Study Data Expected in Q3 2025
July 7, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/07/07/3111003/0/en/silo-pharma-advances-ptsd-drug-spc-15-toward-planned-2025-ind-submission-with-pre-clinical-study-data-expected-in-q3-2025.html
Silo Pharma Faces Nasdaq Non-Compliance Notice
July 3, 2025  |  msn.comhttps://www.msn.com/en-us/money/general/silo-pharma-faces-nasdaq-non-compliance-notice/ar-AA1HVM97

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
August 13f Warren Buffett investing
Buffett Makes Big Moves Outside of UNH: A Buy and Sell Breakdown
By Leo Miller | August 18, 2025
A printed circuit board in blue - stock image
3 Companies That Will Profit From Trump's Semiconductor Tariffs
By Jordan Chussler | August 14, 2025
Robotics surgical
3 Robotics Stocks at the Heart of the Robotics Revolution
By Chris Markoch | August 21, 2025
ON shoes
On Holdings: Correction Is Over, the Sprint to Highs Is On
By Thomas Hughes | August 13, 2025
Customer paying for order of cheese in grocery shop.
Analysts See Big Upside for These 3 Retail Stocks
By Gabriel Osorio-Mazilli | September 4, 2025

Ever-Glory International Group NASDAQ:EVKG

$0.0007 0.00 (0.00%)
As of 09/5/2025

Ever-Glory International Group, Inc., together with its subsidiaries, manufactures, supplies, and retails apparel in Mainland China, Hong Kong, Germany, the United Kingdom, Europe, Japan, and the United States. It operates through two segments, Wholesale and Retail. The company primarily offers casual wear, outerwear, and sportswear. Its products include coats, jackets, slacks, skirts, shirts, trousers, and jeans for women; vests, jackets, trousers, skiwear, shirts, coats, and jeans for men; and coats, vests, down jackets, trousers, knitwear, and jeans for children. The company offers its woman apparel under the La go go, Velwin, Sea To Sky, Jizhu, and idole brands. It also engages in the import and export of apparel, fabric, and accessories. The company provides its products directly to consumers through retail stores, as well as online stores at Tmall, Dangdang mall, JD.com, VIP.com, etc. As of March 31, 2022, it operated 848 stores in China. The company is based in Nanjing, the Peoples Republic of China.

MGO Global stock logo

MGO Global NASDAQ:MGOL

MGO Global, Inc. operates as a lifestyle brand portfolio company. The company is involved in the fashion design, brand development and management, sourcing and manufacturing, licensing, IP protection, corporate finance, consumer engagement and experience, ecommerce, and retail sales and marketing activities related to the Messi brand. MGO Global, Inc. was founded in 2018 and is headquartered in Fort Lauderdale, Florida.

ON stock logo

ON NYSE:ONON

$45.52 -0.53 (-1.14%)
Closing price 09/5/2025 03:59 PM Eastern
Extended Trading
$45.54 +0.02 (+0.05%)
As of 09/5/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

On Holding AG engages in the development and distribution of sports products such as footwear, apparel, and accessories for high-performance running, outdoor, all-day activities, and tennis. It sells its products worldwide through independent retailers and global distributors, its own online presence, and its own stores. The company was founded by David Allemann, Olivier Bernhard, and Caspar Coppetti in January 2010 and is headquartered in Zurich, Switzerland.

Silo Pharma stock logo

Silo Pharma NASDAQ:SILO

$0.61 +0.01 (+1.63%)
Closing price 09/5/2025 04:00 PM Eastern
Extended Trading
$0.62 +0.01 (+1.56%)
As of 09/5/2025 07:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Silo Pharma Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders. It is also developing SP-26, a time-release ketamine-loaded implant for fibromyalgia and chronic pain relief. In addition, the company's two preclinical programs comprise SPC-14, an intranasal compound for the treatment of Alzheimer's disease, and SPU-16, a CNS-homing peptide targeting multiple sclerosis (MS). The company's research and development programs are conducted through collaborations with Columbia University and the University of Maryland, Baltimore. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is based in Sarasota, Florida.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas